Fetal Diagnosis and Therapy is a premier academic journal published by Karger that serves as a vital resource in the fields of embryology, obstetrics, gynecology, pediatric medicine, and radiology. Established in 1986 and running through 2024, the journal is known for its high standards of scholarly excellence, reflected in its impressive Q1 and Q2 quartile rankings across various categories, including pediatrics and embryology. With a focus on advancing the understanding of prenatal diagnosis and treatment modalities, the journal appeals particularly to researchers and healthcare professionals dedicated to improving outcomes in perinatal care. Although it does not offer open access, the journal's rigorous peer-review process ensures that each publication adds substantial value to the medical community. As such, Fetal Diagnosis and Therapy remains an indispensable platform for disseminating cutting-edge research and innovative practices aimed at enhancing fetal health and well-being.

CLINICAL DYSMORPHOLOGY, published by Lippincott Williams & Wilkins, is a pivotal journal in the fields of anatomy, genetics, and pediatric health, with a significant focus on the study of congenital disorders and their phenotypic manifestations. Established in 1992, this esteemed journal has contributed valuable insights into the understanding of dysmorphic syndromes and their clinical implications, making it an essential resource for researchers, clinicians, and students alike. With an impact factor indicative of its robust scholarly influence, CLINICAL DYSMORPHOLOGY engages a diverse readership through specialized articles, case studies, and reviews that advance the knowledge of genetic conditions and associated anatomical anomalies. Although it operates under a non-open access model, the journal is highly regarded with a 2023 ranking of Q3 in Anatomy and Q4 in several other relevant categories, reflecting its ongoing commitment to quality research in the domain of clinical medicine. Researchers and professionals are encouraged to contribute to and explore the rich content of this journal as it continues to shape the discourse in dysmorphology and related fields until its expected convergence in 2024.

ANALES DE PEDIATRIA is a prestigious academic journal dedicated to advancing the field of pediatrics, offering a platform for innovative research and clinical studies. Published by EDICIONES DOYMA S A in Spain, this open-access journal has been committed to disseminating impactful findings since its transition to open access in 2018, ensuring that vital pediatric research is accessible to a global audience. As of 2023, it is categorized in the third quartile (Q3) of pediatrics, perinatology, and child health, reflecting its growing influence, with a Scopus ranking of #176 out of 330 in this competitive field. Covering a wide range of topics with the goal of improving child health outcomes, ANALES DE PEDIATRIA serves as an essential resource for researchers, professionals, and students alike, invitation them to contribute and engage with the latest developments in pediatric medicine.

Clinical Pediatric Endocrinology is a prestigious journal dedicated to advancing the field of pediatric endocrinology, published by the Japanese Society of Pediatric Endocrinology. With a respectable ISSN 0918-5739 and E-ISSN 1347-7358, this journal serves as a critical platform for innovative research spanning various aspects of endocrine disorders in children, including diabetes and metabolic conditions. Although it does not currently offer open access, it remains highly relevant in its category, being ranked in Q4 and Q3 tiers across multiple specialties as of 2023. With a publication history that spans from 1992 to 2024, this journal has contributed significantly to the literature, as evidenced by its inclusion in prominent databases. It invites submissions from researchers and practitioners worldwide, aiming to facilitate knowledge sharing and improve clinical practices in pediatric endocrinology. For those dedicated to enhancing care outcomes in children with endocrine disorders, Clinical Pediatric Endocrinology provides essential insights and fosters a community of engaged professionals.

PROGRESS IN PEDIATRIC CARDIOLOGY is a notable journal dedicated to advancing research and knowledge in the fields of pediatric cardiology and cardiovascular health in children. Published by Elsevier Ireland Ltd, this journal serves as a vital resource for clinicians, researchers, and healthcare professionals who engage with the complexities of heart diseases affecting pediatric populations. With ISSN 1058-9813 for print and 1558-1519 for online issues, it operates from Ireland and reflects a commitment to disseminating high-quality, peer-reviewed research since its inception in 1992. The journal is ranked in the Q3 category in both cardiology and pediatrics, indicating its relevance in the academic community, despite recent performance metrics showing room for growth within the competitive landscape. Researchers and practitioners can expect to find cutting-edge findings and clinical studies that aim to improve outcomes in pediatric cardiology. While it does not offer Open Access, the breadth of research covers various critical aspects, contributing significantly to the field's ongoing development.

European Journal of Pediatric Surgery Reports is a dynamic publication dedicated to the advancement of pediatric surgical practices and research. Published by GEORG THIEME VERLAG KG, this journal serves as an essential resource for clinicians, researchers, and students in the field of pediatric surgery. Since its inception as an Open Access journal in 2013, it has provided unrestricted access to high-quality research articles, case reports, and reviews, facilitating the rapid dissemination of vital information within the medical community. By illuminating key advancements and innovations in pediatric surgical techniques, the journal plays a crucial role in enhancing patient care and outcomes. By fostering collaboration and knowledge exchange among professionals worldwide, European Journal of Pediatric Surgery Reports aspires to establish a scholarly platform that addresses the challenges and developments unique to pediatric surgical medicine. Situated in Stuttgart, Germany, it upholds stringent editorial standards, ensuring that only the most relevant and impactful studies are featured.

Bone Reports is a premier, peer-reviewed journal published by Elsevier that has been committed to advancing the field of orthopedics, sports medicine, and endocrinology since its inception as an open-access journal in 2015. With an ISSN of 2352-1872, this esteemed publication seeks to disseminate high-quality research that spans a diverse array of topics related to bone health, metabolic diseases, and musculoskeletal disorders. The journal boasts an impressive impact factor, contributing significantly to its recognition, with a Q2 ranking in Orthopedics and Sports Medicine and a Q3 ranking in Endocrinology, Diabetes, and Metabolism as of 2023. This open-access model enhances accessibility and engagement, allowing researchers, professionals, and students alike to stay at the forefront of developments in these critical areas. With an emphasis on rigorous methodology and innovative findings, Bone Reports is poised to become a vital resource for anyone interested in the latest advances in bone research and clinical applications.

Fetal and Pediatric Pathology, an esteemed journal published by TAYLOR & FRANCIS INC, is dedicated to advancing the field of pediatric and fetal medicine through the dissemination of high-quality research and clinical insights. With an ISSN of 1551-3815 and an E-ISSN of 1551-3823, the journal has been a key resource for researchers and practitioners since its inception in 1983. Based in the United Kingdom, it covers a broad spectrum of topics relevant to Medicine, Pathology and Forensic Medicine, and Pediatrics, Perinatology, and Child Health, consistently reflecting on contemporary challenges faced in these fields. The journal has attained a commendable Q3 ranking within its categories as of 2023, underlining its relevance in the academic community. Though not an open-access publication, the research presented in Fetal and Pediatric Pathology plays a pivotal role in informing practice, guiding future studies, and enhancing the understanding of diseases affecting fetuses and children. Its convergence of research throughout multiple years, continuing until 2024, marks it as a crucial platform for ongoing scientific dialogue and innovation, aimed at fostering better health outcomes for younger populations.

Molecular Syndromology is a premier journal focused on the intricate connections between molecular genetics and syndromology, fostering discussions that advance our understanding of genetic disorders and their clinical implications. Published by KARGER, a distinguished name in medical and scientific publishing, this journal serves as a valuable platform for researchers, clinicians, and students in the field of genetics. With its ISSN 1661-8769 and E-ISSN 1661-8777, the journal has gained recognition in its category, currently positioned in the Q4 quartile for both genetic and clinical genetics disciplines according to the latest metrics. Despite being indexed lower in Scopus rankings, it addresses crucial gaps in research and offers open access options that enhance visibility and dissemination of knowledge. As it continues to converge from 2010 to 2024, Molecular Syndromology aims to bridge the gap between molecular research and its clinical applications, making a significant impact in the evolving landscape of genetic medicine.

Congenital Heart Disease, published by TECH SCIENCE PRESS, is a pivotal academic journal focusing on the complexities of congenital heart conditions. With an ISSN of 1747-079X and an E-ISSN of 1747-0803, this journal serves as a crucial platform for researchers and healthcare professionals engaged in cardiology, pediatrics, and related fields. Established in 2006 and continuing through to 2024, it aims to disseminate insightful research findings and reviews that advance the understanding of congenital heart diseases and their management. The journal currently holds a Q4 classification in cardiology and cardiovascular medicine, with rankings in various medical categories highlighting its dedication to emerging research. Although it does not offer open access, its contributions are vital for professionals seeking to explore innovative strategies and collaborative solutions in congenital heart disease management. As it continues to navigate the evolving landscape of pediatric cardiac health, Congenital Heart Disease is committed to fostering a community of knowledge that impacts both clinical practices and academic inquiry.